Premium
Antepartum transabdominal amnioinfusion
Author(s) -
Chhabra S.,
Dargan R.,
Nasare M.
Publication year - 2007
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2006.06.009
Subject(s) - amnioinfusion , medicine , oligohydramnios , obstetrics , pregnancy , perinatal mortality , amniotic fluid index , gestational age , gynecology , gestation , fetus , biology , genetics
Objective : To determine the usefulness of antepartum transabdominal amnioinfusion (APTA) in reducing perinatal morbidity and mortality due to oligohydramnios. Methods : In this case‐control study of 100 pregnant women with oligohydramnios, 50 received APTA and 50 were treated conservatively. These controls were matched for age, parity, and pregnancy duration with the case patients. Results : There was a mean 4.02‐cm increase in amniotic fluid index (AFI) after amnioinfusion. Only 18% of case patients required cesarean sections vs. 46% of controls. The perinatal mortality rate was 18% among controls and 4% among case patients, and the difference was significant. Conclusion : Antepartum amnioinfusion is a useful procedure to reduce complications resulting from decreased intra‐amniotic volume. It is especially useful in preterm pregnancies, where the procedure allows for a better perinatal outcome by prolonging the duration of pregnancy.